Loading…
Zimmer Biomet agreed to acquire Monogram Technologies for $177 million in cash plus contingent value rights up to $12.37 per share. Monogram's robotic TKA technology will expand Zimmer Biomet's ROSA Robotics platform.
“Monogram's technology is a major leap forward, demonstrating the potential to significantly increase safety, efficiency and outcomes.”markets.financialcontent.com
Summarized from public sources; check the original articles before acting on it.